Related Experiment Videos
Recent trends in aerosol therapy for allergic rhinitis
Summary
Allergic rhinitis affects 18.1% of outpatients. Sodium cromoglycate was the primary treatment for 50% of patients, including over half of pediatric cases, with about 25% achieving control with this medication alone.
Area of Science:
- Allergy and Immunology
- Pharmacotherapy
- Pediatric Medicine
Background:
- Allergic rhinitis is a common condition affecting a significant portion of the patient population.
- Understanding treatment patterns is crucial for optimizing patient care and resource allocation.
- Sodium cromoglycate and steroid aerosols are established therapies for allergic rhinitis.
Purpose of the Study:
- To analyze the prevalence of allergic rhinitis in an outpatient clinic population.
- To evaluate the prescription patterns and efficacy of sodium cromoglycate and steroid aerosol therapies for allergic rhinitis.
- To assess the usage of these treatments in adult versus pediatric patients.
Main Methods:
- Retrospective analysis of patient records from an outpatient clinic over a four-year period (1980-1983).
- Examination of prescription data for allergic rhinitis treatments, focusing on sodium cromoglycate and steroid aerosols.
- Categorization of patient data by age group (adults and pediatric).
Main Results:
- 18.1% of all analyzed outpatients were diagnosed with allergic rhinitis.
- Sodium cromoglycate was prescribed to approximately 50% of allergic rhinitis patients, representing the main therapy.
- Nearly 50% of patients on sodium cromoglycate received it as monotherapy, achieving control in about 25% of all allergic rhinitis patients. Steroid aerosol therapy, primarily beclomethasone dipropionate, was used in 30-40% of patients, with higher utilization in adults compared to pediatric patients (approx. 10%).
Conclusions:
- Sodium cromoglycate was a widely used and effective monotherapy for allergic rhinitis in this patient cohort.
- Beclomethasone dipropionate usage increased significantly after its launch, becoming a common steroid aerosol therapy, particularly for adults.
- Treatment patterns highlight the importance of both sodium cromoglycate and inhaled corticosteroids in managing allergic rhinitis across different age groups.